<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-99865</identifier>
<setSpec>0304-5013</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Severe oligohydramnios after diclofenac administration in the third trimester of pregnancy</dc:title>
<dc:description xml:lang="en">Objective. To describe the clinical findings in a case of severe fetal oligohydramnios associated with maternal ingestion of diclofenac, as well as to review the adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) during pregnancy. Subjects and methods. We present the case of a woman at 27 weeks of pregnancy with nephritic colic who developed acute oligohydramnios after receiving anti-inflammatory treatment. Results. The oligohydramnios resolved after discontinuation of diclofenac. Conclusions. NSAIDs should be used with caution during pregnancy due to possible adverse effects, including impaired renal function and premature constriction of the ductus arteriosus (AU)</dc:description>
<dc:creator>López del Cerro, Esther</dc:creator>
<dc:creator>González de Merlo, Gaspar</dc:creator>
<dc:creator>Serrano Diana, Carolina</dc:creator>
<dc:creator>Gómez García, Teresa</dc:creator>
<dc:creator>Argüello González, Amparo</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Describir los hallazgos clínicos en un caso de oligoamnios fetal severo asociado a la administración materna de diclofenaco, así como revisar los efectos de los antiinflamatorios no esteroideos (AINE) durante la gestación. Sujetos y métodos. Presentamos un caso clínico que ilustra la complicación descrita en una gestante de 27 semanas con un cólico nefrítico, que desarrolló oligoamnios agudo tras la terapia antiinflamatoria. Resultados. Resolución del oligoamnios tras la supresión de diclofenaco. Conclusiones. El uso de AINE debe realizarse con precaución durante la gestación por sus posibles efectos adversos, entre los que destaca la alteración de la función renal y el cierre prematuro del ductus arterioso (AU)</dc:description>
<dc:source>Prog. obstet. ginecol. (Ed. impr.);55(5): 243-246, mayo 2012.</dc:source>
<dc:identifier>ibc-99865</dc:identifier>
<dc:title xml:lang="es">Oligoamnios severo tras la administración de diclofenaco en el tercer trimestre de gestación</dc:title>
<dc:subject>^d22261</dc:subject>
<dc:subject>^d28018^s22000</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d11688^s22016</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d37778^s22021</dc:subject>
<dc:subject>^d11688^s22067</dc:subject>
<dc:subject>^d29065^s22016</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d29065^s22067</dc:subject>
<dc:subject>^d27938^s22020</dc:subject>
<dc:subject>^d27938^s22000</dc:subject>
<dc:subject>^d28018^s22020</dc:subject>
<dc:subject>^d11705^s22021</dc:subject>
<dc:subject>^d27938^s22002</dc:subject>
<dc:type>article</dc:type>
<dc:date>201205</dc:date>
</metadata>
</record>
</ibecs-document>
